StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Verbindung

Natriumhexafluoroantimonat

Sodium hexafluoroantimonate

HCID 16689647
Neue Reaktion
Drucken
GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
16925-25-0
Standard-SMILES
[F][Sb-]([F])([F])([F])([F])[F].[Na+]
InChIKey
HKLMYZVMEYYVBS-UHFFFAOYSA-H
Summenformel
F6NaSb
Durchschnittliche Molmasse
258,74 g/mol
Monoisotopische Masse
257,8840043

Überblick

Sodium hexafluoroantimonate is a chemical compound of antimony. Antimony is a metallic element with the chemical symbol Sb and atomic number 51. Small amounts of antimony are found in the earth's crust. (L741, L808).

Namen und Bezeichner

Bevorzugter Name
Sodium hexafluoroantimonate
IUPAC
sodium hexafluoroantimony(1-)
Lokaler Name
Natriumhexafluoroantimonat
Englischer Name
Sodium hexafluoroantimonate
Summenformel
F6NaSb
Molmasse
258.74

Namen und Synonyme

Sodium hexafluoroantimonateSodium hexafluoroantimonate(V)7JW6105AEMDTXSID301014504Antimonate(1-), hexafluoro-, sodium, (OC-6-11)-SODIUM HEXAFLUOROANTIMONATE, NaSbF6Antimonate(1-), hexafluoro-, sodium (1:1), (OC-6-11)-sodium hexafluorostibanuideRefChem:183908Sodium hexafluoroantimonic acidDTXCID501437083Antimonate(1), hexafluoro, sodium, (OC611)
Weitere Namen anzeigen
HEXAFLUOROANTIMONATESodium hexafluoroantANTIMONY SODIUM FLUORIDESODIUM ANTIMONY FLUORIDESodium hexafluoroantimotesodiuM hexafluorostibate(V)Sodiumhexafluoroantimonate99%
Antimonate(1), hexafluoro, sodium (1:1), (OC611)240-989-8EINECS 240-989-8UNII-7JW6105AEM16925-25-0sodium;hexafluoroantimony(1-)sodium hexafluorostiboranuidesodium hexafluoro antimonate

Datenbank-Bezeichner

CAS
16925-25-0
PubChem CID
16689647
DTXSID
DTXSID301014504
UNII
7JW6105AEM
EC Number
240-989-8

Eigenschaften

Berechnete Struktureigenschaften

Polarare Oberfläche (TPSA)
0 Ų
H-Brücken-Donoren
0
H-Brücken-Akzeptoren
7
Frei drehbare Bindungen
0
Schwere Atome
8
Formalladung
0
Komplexität
62,7

Experimentelle und physikochemische Eigenschaften

Chemical ClassesMetals -> Metalloid Compounds (Antimony)
Physical DescriptionBeige powder; [Sigma-Aldrich MSDS]

Physikochemische Eigenschaften

Dichte
3.375 g/mL · 3.375 g/mL at 25 °C (lit.)
storage temp.
Inert atmosphere,Room Temperature
Löslichkeit
2 O: · H2O: slightly soluble(lit.)
Aggregatzustand
Powder
Wichte
3.375 · 3.375
Farbe
White to off-white
Wasserlöslichkeit
SOLUBLE
InChI
InChI=1S/6FH.Na.Sb/h6*1H;;/q;;;;;;+1;+5/p-6
InChIKey
HKLMYZVMEYYVBS-UHFFFAOYSA-H
SMILES
[Sb+5]([F-])([F-])([F-])([F-])([F-])[F-].[Na+]
CAS Datenbank
16925 · 16925-25-0(CAS DataBase Reference)
EPA chemische Informationen
Antimonate(1-), hexafluoro-, sodium, (OC-6-11)- (16925-25-0)

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 6 Einträge

This chemical does not meet GHS hazard criteria for 3% (2 of 66) of reports.

Warning

H302 (95.5%): Harmful if swallowed [Warning Acute toxicity, oral]

P261, P264, P270, P271, P273, P301+P317, P304+P340, P317, P330, P391, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 66 reports by companies from 7 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Danger

Gefahrenhinweise

Hazards SummaryA strong eye irritant; Harmful by ingestion and inhalation; [Sigma-Aldrich MSDS] See Antimony and linked occupational diseases.
Hazard Classes and Categories · 2 Einträge

Acute Tox. 4 (95.5%)

Serious eye damage/eye irritation - Category 2B

Sicherheit und Schutzausrüstung

Exposure Control and Personal Protection · 2 Einträge

Biological Exposure Indices (BEI) [ACGIH] - Fluorides in urine = 2 mg/L prior to shift or 3 mg/L at end of shift; (Repeated measurements recommended.)

1.0 [mg/m3], as F, inhalable fraction[German Research Foundation (DFG)]

Threshold Limit Values (TLV)0.5 [mg/m3], as Sb (2.5 mg/m3, as F)
Permissible Exposure Limit (PEL)0.5 [mg/m3], as Sb (2.5 mg/m3, as F)
Immediately Dangerous to Life or Health (IDLH)50.0 [mg/m3], as Sb

Toxikologische Informationen

Treatment · 1 Eintrag

Following oral exposure to antimony, administer charcoal as a slurry (240 mL water/30 g charcoal). Following inhalation exposure, move patient to fresh air. Monitor for respiratory distress. If cough or difficulty breathing develops, evaluate for respiratory tract irritation, bronchitis, or pneumonitis. Administer oxygen and assist ventilation as required. Treat bronchospasm with inhaled beta2 agonist and oral or parenteral corticosteroids. In case of eye exposure, irrigate exposed eyes with copious amounts of room temperature water for at least 15 minutes. Following dermal exposure, Remove contaminated clothing and wash exposed area thoroughly with soap and water. A physician may need to examine the area if irritation or pain persists. (T36)

Health Effects · 1 Eintrag

Dermal exposure to antimony can cause antimony spots (papules and pustules around sweat and sebaceous glands). Antimony poisoning can also lead to pneumoconiosis. Alterations in pulmonary function and other effects including chronic bronchitis, chronic emphysema, inactive tuberculosis, pleural adhesions, and irritation can result from inhalation of antimony. Increased blood pressure can also result from antimony poisoning. Myocardial depression, vasodilation and fluid loss may cause shock with hypotension, electrolyte disturbances and acute renal failure. Cerebral oedema, coma, convulsions, and death are possible. (L741)

Adverse EffectsFibrogenic - Inducing tissue injury and fibrosis (scarring).
Exposure RoutesInhalation (L741) ; oral (L741) ; dermal (L741)
Toxicity Summary · 1 Eintrag

The inhalation data suggests that the myocardium is a target of antimony toxicity. It is possible that antimony affects circulating glucose by interfering with enzymes of the glycogenolysis and gluconeogenesis pathways. The mechanism of action of antimony remains unclear. However, some studies suggest that antimony combines with sulfhydryl groups including those in several enzymes important for tissue respiration. The antidotal action of BAL depends on its ability to prevent or break the union between antimony and vital enzymes. Moreover, the The cause of death is believed to be essentially the same as that in acute arsenic poisoning. (T18, L741, A238)

Signs and Symptoms · 1 Eintrag

Abdominal pain, vomiting, diarrhea can result from inhalation of antimony. Dyspnea, headache, vomiting,cough, conjunctivitis, and bloody purulent discharge from nose can result from inhalation exposure. Skin or eye contact can cause pain and redness of the exposed surface. (T64, L741)

Carcinogen ClassificationNo indication of carcinogenicity (not listed by IARC). (L135)

Sicherheitsdaten

F
1-10
wgk
2
tsca
TSCA listed
ridadr
UN 1549 6.1/PG 3
hs_code
28419085
risk_code
20/22-51/53
hazard_code
Xn,N,T,C
hazard_note
Corrosive/Toxic
safety_code
61
hazard_class
6.1
packing_group
III
Speicherklasse
6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
Hazard Classifications
Acute Tox. 4 InhalationAcute Tox. 4 OralAquatic Chronic 2Eye Irrit. 2

Chemie und Industrie

Pharmakologische Informationen

Metabolism/Metabolites · 1 Eintrag

Antimony is widely distributed throughout the body. The hair and skin contain the highest levels of antimony. The adrenal glands, lung, large intestine, trachea, cerebellum, and kidneys also contain relatively high levels of antimony. Blood is the main vehicle for the transport of absorbed antimony to various tissue compartments of the body. Antimony is a metal and, therefore, does not undergo catabolism. Antimony can covalently interact with sulfhydryl groups and phosphate, as well as numerous reversible binding interactions with endogenous ligands (e.g., proteins). It is not known if these interactions are toxicologically significant. Antimony is excreted via the urine and feces. Some of the fecal antimony may represent unabsorbed antimony that is cleared from the lung via mucociliary action into the esophagus to the gastrointestinal tract. (L741)

Verwendung und Herstellung

UsesBreathing air, drinking water, and eating foods that contain antimony. Exposure can also occur through dermal or skin contact (L741).
General Manufacturing InformationAntimonate(1-), hexafluoro-, sodium (1:1), (OC-6-11)-: ACTIVE

Vor- und nachgelagerte Produkte

Vorgelagerte Rohstoffe

Fluor

Zugehörige Reaktionen

21
Reaktionsaufzeichnung erstellen
Reaktionsgleichung von HRID 6285
HRID 6285als Edukt
Reaktionsgleichung von HRID 6287
HRID 6287als Edukt
Reaktionsgleichung von HRID 378491
HRID 378491als Edukt
Reaktionsgleichung von HRID 378492
HRID 378492als Edukt
Reaktionsgleichung von HRID 654533
HRID 654533als Edukt
Reaktionsgleichung von HRID 654534
HRID 654534als Edukt
Reaktionsgleichung von HRID 703194
HRID 703194als Edukt
Reaktionsgleichung von HRID 1460264
HRID 1460264als Edukt
ZurückSeite 1 von 3

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung